speb/financial-data huggingface dataset:
DuPont ROE decomposition for 9927.HK (quarterly period ending 2025-12-31)
ROE: 1.8890635293134566%
Net margin: 1.1820271893491512%
Asset turnover: 0.42904775961796093
Equity multiplier (leverage): 3.7248900553680313
EBIT margin: 3.506841943621939%
Interest burden factor: 0.40296781979218727
Tax burden factor: 0.8364517777080731
ROE archetype: Low Return
DuPont ROE decomposition for 9927.HK (quarterly period ending 2026-03-31)
ROE: 1.8073134373628084%
Net margin: 2.9304479094195575%
Asset turnover: 0.19371987800999738
Equity multiplier (leverage): 3.1836497652990854
EBIT margin: 3.445482922194936%
Interest burden factor: 0.956931011356478
Tax burden factor: 0.8887984227692504
ROE archetype: Low Return
DuPont ROE decomposition for 9927.T (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.4934927828433537
ROE archetype: Standard Business
DuPont ROE decomposition for 9927.T (quarterly period ending 2025-03-31)
Equity multiplier (leverage): 1.4892306569541103
ROE archetype: Standard Business
DuPont ROE decomposition for 9927.T (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 1.4366415765113705
ROE archetype: Standard Business
DuPont ROE decomposition for 9939.HK (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.7516526115342763
ROE archetype: Standard Business
DuPont ROE decomposition for 9939.HK (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 1.778451328666672
ROE archetype: Standard Business
DuPont ROE decomposition for 9939.HK (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.8385001749863694
ROE archetype: Standard Business
DuPont ROE decomposition for 9958.HK (annual period ending 2021-12-31)
ROE: -15.724299896808173%
Net margin: -24.63388401025715%
Asset turnover: 0.30051725650068933
Equity multiplier (leverage): 2.124070907229917
EBIT margin: -25.123459623948214%
ROE archetype: Low Return
DuPont ROE decomposition for 9958.HK (annual period ending 2022-12-31)
ROE: -83.41540015027465%
Net margin: -1278.7422689330047%
Asset turnover: 0.023966411146240485
Equity multiplier (leverage): 2.7218250768181655
EBIT margin: -924.0344275766619%
ROE archetype: Low Return
DuPont ROE decomposition for 9958.HK (annual period ending 2023-12-31)
ROE: -138.93601638528847%
Net margin: -137.0338049274979%
Asset turnover: 0.14546290247730392
Equity multiplier (leverage): 6.9700336832506276
EBIT margin: -80.76424699193441%
ROE archetype: Low Return
DuPont ROE decomposition for 9958.HK (annual period ending 2024-12-31)
ROE: -369.2096736473511%
Net margin: -285.1352244924949%
Asset turnover: 0.02120511221607578
Equity multiplier (leverage): 61.06349035556771
EBIT margin: -118.8917542815579%
ROE archetype: Low Return
DuPont ROE decomposition for 9972.T (annual period ending 2022-11-30)
ROE: 3.1284352029795492%
Net margin: 2.4680833020164714%
Asset turnover: 0.7812036916080152
Equity multiplier (leverage): 1.622568586001036
EBIT margin: 2.7010219336093955%
Interest burden factor: 1.1269215063520872
Tax burden factor: 0.8108453599115848
ROE archetype: Low Return
DuPont ROE decomposition for 9972.T (annual period ending 2023-11-30)
ROE: -8.058819765581358%
Net margin: -5.75436964102877%
Asset turnover: 0.8163753815551519
Equity multiplier (leverage): 1.715472605433143
EBIT margin: -1.547671508108955%
ROE archetype: Low Return
DuPont ROE decomposition for 9972.T (annual period ending 2024-11-30)
ROE: -0.8476496011075217%
Net margin: -0.5419783096792324%
Asset turnover: 0.87568884743527
Equity multiplier (leverage): 1.786013088286787
EBIT margin: 17.580845097860482%
Interest burden factor: -0.07537050572584869
ROE archetype: Low Return
DuPont ROE decomposition for 9972.T (annual period ending 2025-11-30)
ROE: -20.369431443092427%
Net margin: -11.611934800007088%
Asset turnover: 1.0022500438305997
Equity multiplier (leverage): 1.7502425368664498
EBIT margin: 17.972529793157854%
Interest burden factor: -0.6112784224017631
ROE archetype: Low Return
DuPont ROE decomposition for 9973.T (annual period ending 2022-12-31)
ROE: -213.40641092493578%
Net margin: -9.26361360649533%
Asset turnover: 3.214787368799766
Equity multiplier (leverage): 7.165966551112165
EBIT margin: -5.964431351610971%
ROE archetype: Low Return
DuPont ROE decomposition for 9973.T (annual period ending 2023-12-31)
ROE: -88.21137422138321%
Net margin: -2.5932385330398793%
Asset turnover: 2.888693245904444
Equity multiplier (leverage): 11.775536303768705
EBIT margin: -1.8166596306056473%
ROE archetype: Low Return
DuPont ROE decomposition for 9973.T (annual period ending 2024-12-31)
ROE: -344.8996254815814%
Net margin: -4.321687671802916%
Asset turnover: 2.9564617126519965
Equity multiplier (leverage): 26.99399023564781
EBIT margin: -2.3594934382681796%
ROE archetype: Low Return
DuPont ROE decomposition for 9973.T (annual period ending 2025-12-31)
ROE: -260.38695693525386%
Net margin: -3.5207634059356647%
Asset turnover: 3.342912656359821
Equity multiplier (leverage): 22.1236793330296
EBIT margin: -1.5222597054362892%
ROE archetype: Low Return
DuPont ROE decomposition for 9974.T (quarterly period ending 2026-02-28)
Equity multiplier (leverage): 1.8357588874791648
ROE archetype: Standard Business
DuPont ROE decomposition for 9978.HK (annual period ending 2022-12-31)
ROE: 13.352027519188908%
Net margin: 6.194415415718485%
Asset turnover: 0.8921420331173606
Equity multiplier (leverage): 2.4160887889620097
EBIT margin: 6.453427614294503%
Interest burden factor: 0.9283854954900418
Tax burden factor: 1.0339071465832028
ROE archetype: Standard Business
DuPont ROE decomposition for 9978.HK (annual period ending 2023-12-31)
ROE: -27.487314822274435%
Net margin: -13.381944965134588%
Asset turnover: 0.8018516189935697
Equity multiplier (leverage): 2.5616457249897473
EBIT margin: 6.85006935592712%
Interest burden factor: -2.3083974687874123
ROE archetype: Low Return
DuPont ROE decomposition for 9978.HK (annual period ending 2024-12-31)
ROE: -58.44242176904243%
Net margin: -20.8428045440137%
Asset turnover: 0.8605615109287204
Equity multiplier (leverage): 3.2582929606006754
EBIT margin: 3.2305520711133267%
Interest burden factor: -7.491781281449178
ROE archetype: Low Return
DuPont ROE decomposition for 9978.HK (annual period ending 2025-12-31)
ROE: -118.47290606118202%
Net margin: -14.961967863700124%
Asset turnover: 1.0765687221263038
Equity multiplier (leverage): 7.355099732209503
EBIT margin: 5.309959059859276%
Interest burden factor: -2.951946308724832
ROE archetype: Low Return
DuPont ROE decomposition for 9986.HK (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 2.870746695353601
ROE archetype: Standard Business
DuPont ROE decomposition for 9986.HK (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 3.2954048535083156
ROE archetype: Standard Business
DuPont ROE decomposition for 9987.T (annual period ending 2022-03-31)
ROE: 3.4616957812376663%
Net margin: 0.6463276513189157%
Asset turnover: 1.9611795217203565
Equity multiplier (leverage): 2.7309818423627177
EBIT margin: 0.8983918624883436%
Interest burden factor: 1.1177172400079538
Tax burden factor: 0.6436577121508628
ROE archetype: Low Return
DuPont ROE decomposition for 9987.T (annual period ending 2023-03-31)
ROE: 4.688384564238834%
Net margin: 0.8788989937913314%
Asset turnover: 1.9351326695773434
Equity multiplier (leverage): 2.7565984984658867
EBIT margin: 1.408527977024643%
Interest burden factor: 0.9383223431988958
Tax burden factor: 0.6649996731385239
ROE archetype: Low Return
DuPont ROE decomposition for 9987.T (annual period ending 2024-03-31)
ROE: 6.562450329304593%
Net margin: 1.2158426611768818%
Asset turnover: 1.8852695655935219
Equity multiplier (leverage): 2.8629594370655234
EBIT margin: 1.4613912548664505%
Interest burden factor: 1.2270042436059183
Tax burden factor: 0.6780548220503353
ROE archetype: Standard Business
DuPont ROE decomposition for 9987.T (annual period ending 2025-03-31)
ROE: 8.42727300880752%
Net margin: 1.4376537530750613%
Asset turnover: 2.0620352517361833
Equity multiplier (leverage): 2.84273695659388
EBIT margin: 1.5469059381187624%
Interest burden factor: 1.3545319865319865
Tax burden factor: 0.6861216616620598
ROE archetype: Standard Business
DuPont ROE decomposition for 9987.T (annual period ending 2026-03-31)
ROE: 8.961557098946265%
Net margin: 1.533912935772548%
Asset turnover: 2.120193986654747
Equity multiplier (leverage): 2.755542843623352
EBIT margin: 1.4628131777449713%
Interest burden factor: 1.4925910652920962
Tax burden factor: 0.7025399222735895
ROE archetype: Standard Business
DuPont ROE decomposition for 9988.HK (quarterly period ending 2025-03-31)
ROE: 1.1520897967720571%
Net margin: 5.311392490717011%
Asset turnover: 0.13105557116704272
Equity multiplier (leverage): 1.6550931744252393
EBIT margin: 12.038282287463947%
Interest burden factor: 0.6489724222729668
Tax burden factor: 0.6798570887240838
ROE archetype: Low Return
DuPont ROE decomposition for 9988.HK (quarterly period ending 2025-06-30)
ROE: 3.973987343489908%
Net margin: 17.409913911456396%
Asset turnover: 0.13648702997387205
Equity multiplier (leverage): 1.6723935063864783
EBIT margin: 14.127889134753605%
Interest burden factor: 1.4357493997942152
Tax burden factor: 0.8583031412987219
ROE archetype: Low Return
DuPont ROE decomposition for 9988.HK (quarterly period ending 2025-09-30)
ROE: 1.9130096742313918%
Net margin: 8.482414899412822%
Asset turnover: 0.13329175810785543
Equity multiplier (leverage): 1.6919766244730516
EBIT margin: 2.1650961480255857%
Interest burden factor: 4.458713886300093
Tax burden factor: 0.8786840015049537
ROE archetype: Low Return
DuPont ROE decomposition for 9988.HK (quarterly period ending 2025-12-31)
ROE: 1.490057833608839%
Net margin: 5.751589472095154%
Asset turnover: 0.15271329922418672
Equity multiplier (leverage): 1.6964395355600284
EBIT margin: 7.077583089631832%
Interest burden factor: 1.1842757936507937
Tax burden factor: 0.6861989528795811
ROE archetype: Low Return
DuPont ROE decomposition for 9988.HK (quarterly period ending 2026-03-31)
ROE: 2.3030877078126144%
Net margin: 10.494288766537926%
Asset turnover: 0.12932951235473691
Equity multiplier (leverage): 1.696913977763107
EBIT margin: -0.3484263291971403%
Tax burden factor: 0.8145230729980546
ROE archetype: Low Return
DuPont ROE decomposition for 9989.HK (quarterly period ending 2024-12-31)
ROE: -1.0930243225660112%
Net margin: -11.006215228656785%
Asset turnover: 0.0698698468816107
Equity multiplier (leverage): 1.4213532714534247
EBIT margin: 9.409297479767014%
Interest burden factor: -1.411789979398812
ROE archetype: Low Return
DuPont ROE decomposition for 9989.HK (quarterly period ending 2025-03-31)
ROE: 1.279577526019166%
Net margin: 11.231140964736893%
Asset turnover: 0.08014245648747403
Equity multiplier (leverage): 1.421608709157743
EBIT margin: 10.448091067886928%
Interest burden factor: 1.2235615835900304
Tax burden factor: 0.8785391022670376
ROE archetype: Low Return
DuPont ROE decomposition for 9989.HK (quarterly period ending 2025-06-30)
ROE: 2.174351026792835%
Net margin: 18.63964872296719%
Asset turnover: 0.08234737706454384
Equity multiplier (leverage): 1.4165834504997592
EBIT margin: 16.223827321919742%
Interest burden factor: 1.3227730726184168
Tax burden factor: 0.8685584759024111
ROE archetype: Low Return
DuPont ROE decomposition for 9989.HK (quarterly period ending 2025-12-31)
ROE: -1.6894628578992228%
Net margin: -15.88844827293384%
Asset turnover: 0.07723280286620204
Equity multiplier (leverage): 1.3767825974646508
EBIT margin: 8.14054408044613%
Interest burden factor: -2.289057688777963
ROE archetype: Low Return
DuPont ROE decomposition for 9989.HK (quarterly period ending 2026-03-31)
ROE: 1.5531579205683141%
Net margin: 14.09419410408149%
Asset turnover: 0.07961828273096082
Equity multiplier (leverage): 1.3840843605017974
EBIT margin: 15.23992283315133%
Interest burden factor: 1.0239664827865427
Tax burden factor: 0.9031746491864777
ROE archetype: Low Return
DuPont ROE decomposition for 9991.HK (quarterly period ending 2025-03-31)
ROE: -1.1066798691633517%
Net margin: -3.055668584936736%
Asset turnover: 0.21240109355140707
Equity multiplier (leverage): 1.7051359560078962
EBIT margin: -4.0685733108566335%
ROE archetype: Low Return
DuPont ROE decomposition for 9991.HK (quarterly period ending 2025-06-30)
ROE: -0.3621500702232834%
Net margin: -0.8012814862608079%
Asset turnover: 0.26562497521835043
Equity multiplier (leverage): 1.7015102061381564
EBIT margin: -0.3673813326563927%
ROE archetype: Low Return
DuPont ROE decomposition for 9991.HK (quarterly period ending 2025-09-30)
ROE: -1.699099972737264%
Net margin: -4.392565927445722%
Asset turnover: 0.22293233224611297
Equity multiplier (leverage): 1.7351122859235972
EBIT margin: -1.188043598236555%
ROE archetype: Low Return
DuPont ROE decomposition for 9991.HK (quarterly period ending 2025-12-31)
ROE: -0.22241402655765663%
Net margin: -0.3828224200782542%
Asset turnover: 0.32845365475159616
Equity multiplier (leverage): 1.768848792677552
EBIT margin: 6.113526518270439%
Interest burden factor: -0.14669347977415115
ROE archetype: Low Return
DuPont ROE decomposition for 9991.HK (quarterly period ending 2026-03-31)
ROE: -0.03236883497049534%
Net margin: -0.07408468248791819%
Asset turnover: 0.2453105615746714
Equity multiplier (leverage): 1.7810757795723928
EBIT margin: 0.010499529831054167%
Interest burden factor: 28.139999999999997
Tax burden factor: -0.2507462686567164
ROE archetype: Low Return
DuPont ROE decomposition for 9994.T (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.7387637236962488
ROE archetype: Standard Business
DuPont ROE decomposition for 9994.T (quarterly period ending 2025-03-31)
Equity multiplier (leverage): 1.7662802642173308
ROE archetype: Standard Business
DuPont ROE decomposition for 9994.T (quarterly period ending 2025-09-30)
Equity multiplier (leverage): 1.6457645764576458
ROE archetype: Standard Business
DuPont ROE decomposition for 9994.T (quarterly period ending 2026-03-31)
Equity multiplier (leverage): 1.643963982981058
ROE archetype: Standard Business
DuPont ROE decomposition for AA4.L (annual period ending 2022-03-31)
ROE: 7.887219242219381%
Net margin: 14.0939780975027%
Asset turnover: 0.12606293456491963
Equity multiplier (leverage): 4.439181564506547
Tax burden factor: 1.0028800637375543
ROE archetype: Standard Business
DuPont ROE decomposition for AA4.L (annual period ending 2023-03-31)
ROE: 17.406658848191555%
Net margin: 30.333020354322443%
Asset turnover: 0.13489417474383683
Equity multiplier (leverage): 4.254088941801354
Tax burden factor: 0.9994618212862937
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for AA4.L (annual period ending 2024-03-31)
ROE: 7.785499618686055%
Net margin: 17.26341155236111%
Asset turnover: 0.11615423861419148
Equity multiplier (leverage): 3.882619231201558
Tax burden factor: 0.9989559270166625
ROE archetype: Standard Business
DuPont ROE decomposition for AA4.L (annual period ending 2025-03-31)
ROE: 4.392645959300262%
Net margin: 10.027705331918412%
Asset turnover: 0.11862555999047521
Equity multiplier (leverage): 3.6927198593411883
Tax burden factor: 0.9980703353795567
ROE archetype: Low Return
DuPont ROE decomposition for AAA.PA (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 6.273119448975893
ROE archetype: Standard Business
DuPont ROE decomposition for AAA.PA (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 6.988156122771973
ROE archetype: Standard Business
DuPont ROE decomposition for AAA.PA (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 7.6734659514588826
ROE archetype: Standard Business
DuPont ROE decomposition for AAL.AX (annual period ending 2022-06-30)
Net margin: 4.23841059602649%
EBIT margin: 3.576158940397351%
Interest burden factor: 1.6666666666666665
Tax burden factor: 0.7111111111111112
ROE archetype: Standard Business
DuPont ROE decomposition for AAL.AX (annual period ending 2023-06-30)
Net margin: 5.805687203791469%
EBIT margin: 8.886255924170614%
Interest burden factor: 0.9466666666666668
Tax burden factor: 0.6901408450704225
ROE archetype: Standard Business
DuPont ROE decomposition for AAL.AX (annual period ending 2024-06-30)
ROE: 12.915555536757694%
Net margin: 3.8064718447861177%
Asset turnover: 1.662920168448269
Equity multiplier (leverage): 2.0404176368126064
EBIT margin: 10.437003245397012%
Interest burden factor: 0.959221558948296
Tax burden factor: 0.38021379687740264
ROE archetype: Standard Business
DuPont ROE decomposition for AAL.AX (annual period ending 2025-06-30)
ROE: 19.830335031328676%
Net margin: 12.817605167817614%
Asset turnover: 0.7598792085731974
Equity multiplier (leverage): 2.036003875809553
EBIT margin: 17.368624830806205%
Interest burden factor: 1.0723933778034123
Tax burden factor: 0.6881566827025208
ROE archetype: Balanced Compounder
DuPont ROE decomposition for AAPG (annual period ending 2022-12-31)
ROE: -216.05450034013757%
Net margin: -421.0194028925521%
Asset turnover: 0.07409599326705205
Equity multiplier (leverage): 6.925744754782723
EBIT margin: -405.22910100090127%
ROE archetype: Low Return
DuPont ROE decomposition for AAPG (annual period ending 2023-12-31)
ROE: -379.28381469317367%
Net margin: -416.9836564797463%
Asset turnover: 0.08234360859875214
Equity multiplier (leverage): 11.046263062135097
EBIT margin: -393.10761135937724%
ROE archetype: Low Return
DuPont ROE decomposition for AAPG (annual period ending 2024-12-31)
ROE: -233.89365016690977%
Net margin: -41.343292714016215%
Asset turnover: 0.37826270514506544
Equity multiplier (leverage): 14.956151137028208
EBIT margin: -37.70254423086728%
ROE archetype: Low Return
DuPont ROE decomposition for AAPG (annual period ending 2025-12-31)
ROE: -155.62751233360152%
Net margin: -216.4650247335052%
Asset turnover: 0.17736707607621566
Equity multiplier (leverage): 4.053457588933744
EBIT margin: -208.61335609280292%
ROE archetype: Low Return
DuPont ROE decomposition for AARTIDRUGS.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.9013702575307818
ROE archetype: Standard Business
DuPont ROE decomposition for AARTIDRUGS.NS (quarterly period ending 2025-03-31)
ROE: 4.699971527199423%
Net margin: 9.288374017376915%
Asset turnover: 0.2676504030835209
Equity multiplier (leverage): 1.8905476600552902
EBIT margin: 11.589041905549974%
Interest burden factor: 0.9071783756215733
Tax burden factor: 0.883485593815882
ROE archetype: Low Return
DuPont ROE decomposition for AARTIDRUGS.NS (quarterly period ending 2025-06-30)
Net margin: 9.139557331797937%
EBIT margin: 10.05232764898139%
Interest burden factor: 0.8610175202156335
Tax burden factor: 1.0559577382117002
ROE archetype: Standard Business
DuPont ROE decomposition for AARTIDRUGS.NS (quarterly period ending 2025-09-30)
ROE: 3.083229492234047%
Net margin: 6.936380765636729%
Asset turnover: 0.24989377055204856
Equity multiplier (leverage): 1.7787605798759352
EBIT margin: 10.421421896781508%
Interest burden factor: 0.8879905923857123
Tax burden factor: 0.7495447773547426
ROE archetype: Low Return
DuPont ROE decomposition for AARTIDRUGS.NS (quarterly period ending 2025-12-31)
Net margin: 6.7391268218909435%
EBIT margin: 6.164098984560669%
Interest burden factor: 0.7824211377729847
Tax burden factor: 1.3973121984838042
ROE archetype: Standard Business
DuPont ROE decomposition for AARTIDRUGS.NS (quarterly period ending 2026-03-31)
ROE: 3.566945683666526%
Net margin: 7.67180341524365%
Asset turnover: 0.2558555870505743
Equity multiplier (leverage): 1.8172058460729321
EBIT margin: 10.795501874219077%
Interest burden factor: 0.904835390946502
Tax burden factor: 0.7853894258101195
ROE archetype: Low Return
DuPont ROE decomposition for AARTIIND.NS (annual period ending 2023-03-31)
ROE: 11.080108925377987%
Net margin: 8.398283468059937%
Asset turnover: 0.7565826428463215
Equity multiplier (leverage): 1.7438018208421395
EBIT margin: 12.256013406940063%
Interest burden factor: 0.7680223205308667
Tax burden factor: 0.8922107674684995
ROE archetype: Standard Business
DuPont ROE decomposition for AARTIIND.NS (annual period ending 2024-03-31)
ROE: 8.095555551706697%
Net margin: 6.7261119338984985%
Asset turnover: 0.6576096446688596
Equity multiplier (leverage): 1.8302667614216863
EBIT margin: 10.006960942812059%
Interest burden factor: 0.6381859264041317
Tax burden factor: 1.053209245865156
ROE archetype: Standard Business
DuPont ROE decomposition for AARTIIND.NS (annual period ending 2025-03-31)
ROE: 6.000664303243105%
Net margin: 4.553583711652222%
Asset turnover: 0.676516940511335
Equity multiplier (leverage): 1.947903018281519
EBIT margin: 7.786490576420416%
Interest burden factor: 0.5424028268551236
Tax burden factor: 1.0781758957654723
ROE archetype: Standard Business
DuPont ROE decomposition for AARTIIND.NS (annual period ending 2026-03-31)
ROE: 6.903840040801986%
Net margin: 5.056722181993724%
Asset turnover: 0.6483966035509937
Equity multiplier (leverage): 2.1056243542776865
EBIT margin: 8.17040791696838%
Interest burden factor: 0.5391432791728213
Tax burden factor: 1.147945205479452
ROE archetype: Standard Business
DuPont ROE decomposition for AARTIPHARM.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 1.4953799608741556
ROE archetype: Standard Business
DuPont ROE decomposition for AARTIPHARM.NS (quarterly period ending 2025-03-31)
ROE: 4.545452763390407%
Net margin: 15.66945795944141%
Asset turnover: 0.19632593122160688
Equity multiplier (leverage): 1.4775613056257133
EBIT margin: 21.78350659924048%
Interest burden factor: 0.9333061369395427
Tax burden factor: 0.7707296389713113
ROE archetype: Low Return
DuPont ROE decomposition for AARTIPHARM.NS (quarterly period ending 2025-06-30)
Net margin: 12.81783180287262%
EBIT margin: 18.760177932727053%
Interest burden factor: 0.9034452678464212
Tax burden factor: 0.756268075478155
ROE archetype: Standard Business
DuPont ROE decomposition for AARTIPHARM.NS (quarterly period ending 2025-09-30)
ROE: 1.3646282660940816%
Net margin: 6.674821219750306%
Asset turnover: 0.1280915593214682
Equity multiplier (leverage): 1.5960783706192574
EBIT margin: 11.940077660285493%
Interest burden factor: 0.7746263726363628
Tax burden factor: 0.7216725851722052
ROE archetype: Low Return
DuPont ROE decomposition for AARTIPHARM.NS (quarterly period ending 2025-12-31)
Net margin: 11.093830352923051%
EBIT margin: 17.047271317388304%
Interest burden factor: 0.8531442909349484
Tax burden factor: 0.7627885373985189
ROE archetype: Standard Business
DuPont ROE decomposition for AARTIPHARM.NS (quarterly period ending 2026-03-31)
ROE: 2.8769634181831565%
Net margin: 10.49081428797001%
Asset turnover: 0.16734440436224093
Equity multiplier (leverage): 1.6387546822239452
EBIT margin: 17.500463404754875%
Interest burden factor: 0.8010423143536926
Tax burden factor: 0.7483490167559189
ROE archetype: Low Return
DuPont ROE decomposition for AATG.L (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.0112088174438962
ROE archetype: Standard Business
DuPont ROE decomposition for AATG.L (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.0085166653649391
ROE archetype: Standard Business
DuPont ROE decomposition for AAU.L (annual period ending 2022-12-31)
ROE: 14.87743650324867%
Asset turnover: 0
Equity multiplier (leverage): 1.030050206733609
Tax burden factor: 0.8032688857883198
ROE archetype: Standard Business
DuPont ROE decomposition for AAU.L (annual period ending 2023-12-31)
ROE: -0.9218430543604134%
Asset turnover: 0
Equity multiplier (leverage): 1.0252401280411167
Tax burden factor: -3.694915254237288
ROE archetype: Low Return
DuPont ROE decomposition for AAU.L (annual period ending 2024-12-31)
ROE: 8.258513674906165%
Asset turnover: 0
Equity multiplier (leverage): 1.0400394309194871
Tax burden factor: 0.9929915160457395
ROE archetype: Standard Business
DuPont ROE decomposition for AAU.L (annual period ending 2025-12-31)
ROE: -28.904344684310356%
Asset turnover: 0
Equity multiplier (leverage): 1.036668879509398
ROE archetype: Low Return
DuPont ROE decomposition for ABBV (quarterly period ending 2025-03-31)
ROE: 88.16689466484267%
Net margin: 9.660496140298283%
Asset turnover: 0.09799140748356773
Equity multiplier (leverage): 93.13611491108071
EBIT margin: 29.835868994978643%
Interest burden factor: 0.4172318512936448
Tax burden factor: 0.7760385310054184
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for ABBV (quarterly period ending 2025-06-30)
ROE: 142.14501510574019%
Net margin: 6.1012773131038065%
Asset turnover: 0.11284557723333345
Equity multiplier (leverage): 206.45543806646526
EBIT margin: 37.06801530182196%
Interest burden factor: 0.2718208850795872
Tax burden factor: 0.6055341055341056
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for ABBV (quarterly period ending 2025-09-30)
Net margin: 1.191683569979716%
Asset turnover: 0.11639368452117456
EBIT margin: 29.056795131845842%
Interest burden factor: 0.15575916230366493
Tax burden factor: 0.26330532212885155
ROE archetype: Standard Business
DuPont ROE decomposition for ABBV (quarterly period ending 2025-12-31)
Net margin: 10.927909495727524%
Asset turnover: 0.12408066960852392
EBIT margin: 34.956071729449995%
Interest burden factor: 0.4592873127904975
Tax burden factor: 0.6806596701649176
ROE archetype: Standard Business
DuPont ROE decomposition for ABBV (quarterly period ending 2026-03-31)
Net margin: 4.646047193707506%
Asset turnover: 0.11095210096774313
EBIT margin: 31.55579256099187%
Interest burden factor: 0.21947613012251796
Tax burden factor: 0.670837343599615
ROE archetype: Standard Business
DuPont ROE decomposition for ABCB (quarterly period ending 2025-03-31)
ROE: 2.299674512435529%
Net margin: 31.714116722087176%
Asset turnover: 0.010457274276313655
Equity multiplier (leverage): 6.934182261529232
Tax burden factor: 0.7786268328965078
ROE archetype: Low Return
DuPont ROE decomposition for ABCB (quarterly period ending 2025-06-30)
ROE: 2.83754527558038%
Net margin: 37.59249751856796%
Asset turnover: 0.010984847794137704
Equity multiplier (leverage): 6.871437115383622
Tax burden factor: 0.7697278053429765
ROE archetype: Low Return
DuPont ROE decomposition for ABCB (quarterly period ending 2025-09-30)
ROE: 2.6726477270621936%
Net margin: 34.72648906414783%
Asset turnover: 0.011354633774328894
Equity multiplier (leverage): 6.778095929120603
Tax burden factor: 0.7736971147531414
ROE archetype: Low Return
DuPont ROE decomposition for ABCB (quarterly period ending 2025-12-31)
ROE: 2.677860583247011%
Net margin: 36.2498912730752%
Asset turnover: 0.010946081665736166
Equity multiplier (leverage): 6.748738033857306
Tax burden factor: 0.7679702893106723
ROE archetype: Low Return
DuPont ROE decomposition for ABCB (quarterly period ending 2026-03-31)
ROE: 2.708749711178569%
Net margin: 36.053473946623946%
Asset turnover: 0.011018876955220826
Equity multiplier (leverage): 6.8184306378096515
Tax burden factor: 0.7851625510747913
ROE archetype: Low Return
DuPont ROE decomposition for ABEO.PA (annual period ending 2022-03-31)
ROE: 6.801262187287431%
Net margin: 3.5063707917705735%
Asset turnover: 0.5952487257840995
Equity multiplier (leverage): 3.258616128788451
EBIT margin: 7.3741427680798%
Interest burden factor: 0.6614927344782036
Tax burden factor: 0.7188217673489765
ROE archetype: Standard Business
DuPont ROE decomposition for ABEO.PA (annual period ending 2023-03-31)
ROE: 6.13224677492957%
Net margin: 2.8234622664075975%
Asset turnover: 0.7045115491254333
Equity multiplier (leverage): 3.082829587503309
EBIT margin: 6.531144954236242%
Interest burden factor: 0.6333611771509349
Tax burden factor: 0.6825606168205337
ROE archetype: Standard Business
DuPont ROE decomposition for ABEO.PA (annual period ending 2024-03-31)
ROE: 1.5333518346356347%
Net margin: 0.6840049921494423%
Asset turnover: 0.7873680446558414
Equity multiplier (leverage): 2.8471133701142364
EBIT margin: 5.4664036394379805%
Interest burden factor: 0.7874502872293415
Tax burden factor: 0.1589038533482978
ROE archetype: Low Return
DuPont ROE decomposition for ABEO.PA (annual period ending 2025-03-31)
ROE: 6.177196962354445%
Net margin: 2.748648996397324%
Asset turnover: 0.8302653824576643
Equity multiplier (leverage): 2.706794185011882
EBIT margin: 6.037699433865157%
Interest burden factor: 0.5778502930207778
Tax burden factor: 0.7878298951250433
ROE archetype: Standard Business
DuPont ROE decomposition for ABEV (quarterly period ending 2025-03-31)
ROE: 3.984931526276151%
Net margin: 11.305383885729793%
Asset turnover: 0.22847019190811907
Equity multiplier (leverage): 1.5427871144102616
EBIT margin: 16.728772280123874%
Interest burden factor: 0.8626133587220162
Tax burden factor: 0.783438779575998
ROE archetype: Low Return
DuPont ROE decomposition for ABEV (quarterly period ending 2025-06-30)
ROE: 3.032471370525814%
Net margin: 9.41243223200643%
Asset turnover: 0.21004650951513412
Equity multiplier (leverage): 1.533837594132738
EBIT margin: 14.242142069824665%
Interest burden factor: 0.8098772706539455
Tax burden factor: 0.81603227908141
ROE archetype: Low Return
DuPont ROE decomposition for ABEV (quarterly period ending 2025-09-30)
ROE: 5.309219785785558%
Net margin: 15.677781383703168%
Asset turnover: 0.2225770890759456
Equity multiplier (leverage): 1.5214778763430883
EBIT margin: 16.989852564928253%
Interest burden factor: 0.9892099134015486
Tax burden factor: 0.9328386548858318
ROE archetype: Standard Business
DuPont ROE decomposition for ABEV (quarterly period ending 2025-12-31)
ROE: 4.9155298166563375%
Net margin: 12.232341697165388%
Asset turnover: 0.2553032586313245
Equity multiplier (leverage): 1.5739987118574919
EBIT margin: 19.964494472799554%
Interest burden factor: 0.8023981636704838
Tax burden factor: 0.7635919833264411
ROE archetype: Low Return
DuPont ROE decomposition for ABEV (quarterly period ending 2026-03-31)
ROE: 4.414551513054472%
Net margin: 11.55270047112976%
Asset turnover: 0.23851498639144264
Equity multiplier (leverage): 1.6020918222936988
EBIT margin: 17.447687208870203%
Interest burden factor: 0.8403662623895497
Tax burden factor: 0.7879107716322946
ROE archetype: Low Return
DuPont ROE decomposition for ABF.L (annual period ending 2023-08-31)
ROE: 9.54167783436076%
Net margin: 5.40759493670886%
Asset turnover: 1.0480789641265125
Equity multiplier (leverage): 1.6835522201375859
EBIT margin: 6.784810126582279%
Interest burden factor: 1
Tax burden factor: 0.7970149253731343
ROE archetype: Standard Business
DuPont ROE decomposition for ABF.L (annual period ending 2023-09-30)
ROE: 9.363882595211182%
Net margin: 5.407594936708861%
Asset turnover: 1.0285495424347142
Equity multiplier (leverage): 1.6835522201375859
EBIT margin: 6.784810126582277%
Interest burden factor: 1
Tax burden factor: 0.7970149253731343
ROE archetype: Standard Business
DuPont ROE decomposition for ABF.L (annual period ending 2024-08-31)
ROE: 13.670792536486234%
Net margin: 7.373088227967918%
Asset turnover: 1.1005184381865762
Equity multiplier (leverage): 1.6847945100548363
EBIT margin: 9.136651223035921%
Interest burden factor: 1.04525627044711
Tax burden factor: 0.772039645279082
ROE archetype: Standard Business
DuPont ROE decomposition for ABF.L (annual period ending 2025-08-31)
ROE: 9.42834010404177%
Net margin: 5.370265686828716%
Asset turnover: 1.0294505824961575
Equity multiplier (leverage): 1.7054302585373846
EBIT margin: 8.104219127396064%
Interest burden factor: 0.896005072923272
Tax burden factor: 0.7395612172682235
ROE archetype: Standard Business
DuPont ROE decomposition for ABFRL.NS (quarterly period ending 2024-09-30)
Equity multiplier (leverage): 5.528580692977577
ROE archetype: Standard Business
DuPont ROE decomposition for ABFRL.NS (quarterly period ending 2024-12-31)
Net margin: -1.924999545561958%
EBIT margin: 0.23994328613236868%
Interest burden factor: -22.617424242424246
ROE archetype: Standard Business
DuPont ROE decomposition for ABFRL.NS (quarterly period ending 2025-03-31)
ROE: -0.14956063810581965%
Net margin: -0.5926210249610347%
Asset turnover: 0.10333723970071215
Equity multiplier (leverage): 2.442212205850624
EBIT margin: -6.378091050782795%
ROE archetype: Low Return
DuPont ROE decomposition for ABFRL.NS (quarterly period ending 2025-06-30)
Net margin: -12.761949482926191%
EBIT margin: -11.13483231957018%
ROE archetype: Standard Business
DuPont ROE decomposition for ABFRL.NS (quarterly period ending 2025-12-31)
Net margin: -5.784316203668596%
EBIT margin: -1.718443247979913%
ROE archetype: Standard Business
DuPont ROE decomposition for ABFRL.NS (quarterly period ending 2026-03-31)
ROE: -2.3695093327372305%
Net margin: -7.456799304568045%
Asset turnover: 0.11207453877863627
Equity multiplier (leverage): 2.8352999409219373
EBIT margin: -7.627139935582098%
ROE archetype: Low Return
DuPont ROE decomposition for ABO.DE (quarterly period ending 2024-12-31)
ROE: -0.5846851189842669%
Net margin: -10.834483798740093%
Asset turnover: 0.02291425199111045
Equity multiplier (leverage): 2.355093378076343
EBIT margin: -15.433251737299441%
ROE archetype: Low Return
DuPont ROE decomposition for ABO.DE (quarterly period ending 2025-03-31)
ROE: -0.18481561301564592%
Net margin: -3.1336125518109417%
Asset turnover: 0.024561038047329696
Equity multiplier (leverage): 2.401301217958674
EBIT margin: 14.042664004687397%
Interest burden factor: -0.27731417091639626
ROE archetype: Low Return
DuPont ROE decomposition for ABO.DE (quarterly period ending 2025-06-30)
ROE: 0.8364860388785151%
Net margin: 14.350469995990556%
Asset turnover: 0.022907790517506802
Equity multiplier (leverage): 2.5445405070738825
EBIT margin: 39.81044237537311%
Interest burden factor: 0.46129528605399356
Tax burden factor: 0.7814300442719389
ROE archetype: Low Return
DuPont ROE decomposition for ABO.DE (quarterly period ending 2025-09-30)
ROE: -0.9489636459881892%
Net margin: -16.31907726187491%
Asset turnover: 0.021867825614300257
Equity multiplier (leverage): 2.659183912818838
EBIT margin: 6.870387127018216%
Interest burden factor: -2.930339574738178
ROE archetype: Low Return
DuPont ROE decomposition for ABO.DE (quarterly period ending 2025-12-31)
ROE: -6.53936321558098%
Net margin: -94.64007810309995%
Asset turnover: 0.025114736667059136
Equity multiplier (leverage): 2.7512606781947753
EBIT margin: 8.526577286303926%
Interest burden factor: -13.30268677020746
ROE archetype: Low Return
DuPont ROE decomposition for ABR.V (quarterly period ending 2024-10-31)
ROE: -1.6631366299460912%
Asset turnover: 0
Equity multiplier (leverage): 1.0561964548508076
ROE archetype: Low Return
DuPont ROE decomposition for ABR.V (quarterly period ending 2025-01-31)
ROE: 1.1654701935327643%
Asset turnover: 0
Equity multiplier (leverage): 1.0699306796924752
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for ABR.V (quarterly period ending 2025-04-30)
ROE: 3.0641177774276454%
Asset turnover: 0
Equity multiplier (leverage): 1.0634552466362368
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for ABR.V (quarterly period ending 2025-10-31)
ROE: -2.237585529640491%
Asset turnover: 0
Equity multiplier (leverage): 1.0284404388959678
ROE archetype: Low Return
DuPont ROE decomposition for ABR.V (quarterly period ending 2026-01-31)
ROE: -1.9499073968426441%
Asset turnover: 0
Equity multiplier (leverage): 1.0124540852738981
ROE archetype: Low Return
DuPont ROE decomposition for ABR.V (quarterly period ending 2026-04-30)
ROE: -0.8304269976402107%
Asset turnover: 0
Equity multiplier (leverage): 1.0072823236700241
ROE archetype: Low Return
DuPont ROE decomposition for ABV.AX (annual period ending 2022-06-30)
ROE: 12.107539011092312%
Net margin: 5.808080808080809%
Asset turnover: 1.4478976234003658
Equity multiplier (leverage): 1.4397443128407597
EBIT margin: 0.6854256854256854%
Interest burden factor: 8.473684210526317
Tax burden factor: 1
ROE archetype: Standard Business
DuPont ROE decomposition for ABV.AX (annual period ending 2023-06-30)
ROE: 23.610261123544866%
Net margin: 10.41696113074205%
Asset turnover: 1.4946749359750244
Equity multiplier (leverage): 1.5163972727734683
EBIT margin: 7.095406360424028%
Interest burden factor: 1.4681274900398407
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for ABV.AX (annual period ending 2024-06-30)
ROE: 21.61340329370378%
Net margin: 11.146725976319747%
Asset turnover: 1.289203187128616
Equity multiplier (leverage): 1.504022945299116
EBIT margin: 6.430300255118729%
Interest burden factor: 1.7334689725330619
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for ABV.AX (annual period ending 2025-06-30)
ROE: 18.007682603465767%
Net margin: 9.304270555642674%
Asset turnover: 1.371959418514675
Equity multiplier (leverage): 1.4106985868015827
EBIT margin: 6.136636872092415%
Interest burden factor: 1.5161839863713797
Tax burden factor: 1
ROE archetype: Balanced Compounder
DuPont ROE decomposition for ABX.AX (quarterly period ending 2024-12-31)
Equity multiplier (leverage): 1.7404008908685968
ROE archetype: Standard Business
DuPont ROE decomposition for ABX.AX (quarterly period ending 2025-12-31)
Equity multiplier (leverage): 1.6761275296195652
ROE archetype: Standard Business
DuPont ROE decomposition for ABY.AX (quarterly period ending 2025-06-30)
Equity multiplier (leverage): 2.081642284096272
ROE archetype: Standard Business
DuPont ROE decomposition for ABZ.V (quarterly period ending 2025-03-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for ABZ.V (quarterly period ending 2025-06-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for ABZ.V (quarterly period ending 2025-09-30)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for ABZ.V (quarterly period ending 2025-12-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for ABZ.V (quarterly period ending 2026-03-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for ACEINTEG.NS (annual period ending 2022-03-31)
ROE: 5.512249443207127%
Net margin: 11.327231121281464%
Asset turnover: 0.3893095768374165
Equity multiplier (leverage): 1.25
EBIT margin: 14.302059496567507%
Interest burden factor: 1.176
Tax burden factor: 0.673469387755102
ROE archetype: Standard Business
DuPont ROE decomposition for ACEINTEG.NS (annual period ending 2023-03-31)
ROE: 2.4805369052778947%
Net margin: 6.801736613603474%
Asset turnover: 0.3080951176284595
Equity multiplier (leverage): 1.1836984151647798
EBIT margin: 12.445730824891463%
Interest burden factor: 0.7790697674418605
Tax burden factor: 0.7014925373134328
ROE archetype: Low Return
DuPont ROE decomposition for ACEINTEG.NS (annual period ending 2024-03-31)
ROE: 2.1710411642265486%
Net margin: 4.485776805251641%
Asset turnover: 0.4424768820343604
Equity multiplier (leverage): 1.0938047672158013
EBIT margin: 0.32822757111597367%
Interest burden factor: 12.333333333333334
Tax burden factor: 1.1081081081081081
ROE archetype: Low Return
DuPont ROE decomposition for ACEINTEG.NS (annual period ending 2025-03-31)
ROE: -8.418634889493786%
Net margin: -18.24561403508772%
Asset turnover: 0.4364806589103449
Equity multiplier (leverage): 1.0571051460242447
EBIT margin: -29.94152046783626%
ROE archetype: Low Return
DuPont ROE decomposition for ACEINTEG.NS (annual period ending 2026-03-31)
ROE: -5.272133172567106%
Net margin: -117.28395061728396%
Asset turnover: 0.04369211672948735
Equity multiplier (leverage): 1.0288325601567698
EBIT margin: -211.11111111111111%
ROE archetype: Low Return
DuPont ROE decomposition for ACHR (annual period ending 2022-12-31)
ROE: -64.3219136428137%
Asset turnover: 0
Equity multiplier (leverage): 1.163186701804176
ROE archetype: Low Return
DuPont ROE decomposition for ACHR (annual period ending 2023-12-31)
ROE: -106.43886564388656%
Asset turnover: 0
Equity multiplier (leverage): 1.3111343561134357
ROE archetype: Low Return
DuPont ROE decomposition for ACHR (annual period ending 2024-12-31)
ROE: -95.88282575689917%
Asset turnover: 0
Equity multiplier (leverage): 1.3892113959096186
ROE archetype: Low Return
DuPont ROE decomposition for ACHR (annual period ending 2025-12-31)
ROE: -41.83528456384922%
Net margin: -206066.66666666666%
Asset turnover: 0.00017305529116552737
Equity multiplier (leverage): 1.1731406916153482
EBIT margin: -243100%
ROE archetype: Low Return
DuPont ROE decomposition for ACM (quarterly period ending 2025-03-31)
ROE: 6.468833513698932%
Net margin: 4.230020418319695%
Asset turnover: 0.32012014734167343
Equity multiplier (leverage): 4.777167864080701
EBIT margin: 6.647209032315882%
Interest burden factor: 0.8820974284722803
Tax burden factor: 0.7214173313798904
ROE archetype: Standard Business
DuPont ROE decomposition for ACM (quarterly period ending 2025-06-30)
ROE: 6.185492358794724%
Net margin: 3.822886053168168%
Asset turnover: 0.34771056950458373
Equity multiplier (leverage): 4.653342606195832
EBIT margin: 6.911359263265717%
Interest burden factor: 0.9306686242801788
Tax burden factor: 0.594337060257102
ROE archetype: Standard Business
DuPont ROE decomposition for ACM (quarterly period ending 2025-09-30)
ROE: 5.105148690708757%
Net margin: 3.298017898571568%
Asset turnover: 0.3415139638270183
Equity multiplier (leverage): 4.532595065349173
EBIT margin: 6.979542402591166%
Interest burden factor: 0.7127185382173801
Tax burden factor: 0.6629915649193082
ROE archetype: Standard Business
DuPont ROE decomposition for ACM (quarterly period ending 2025-12-31)
ROE: 3.6310037905933927%
Net margin: 2.436858396892165%
Asset turnover: 0.3173810085506447
Equity multiplier (leverage): 4.694782454634331
EBIT margin: 6.268896015854511%
Interest burden factor: 0.8258928757323517
Tax burden factor: 0.47066890525816907
ROE archetype: Low Return
DuPont ROE decomposition for ACM (quarterly period ending 2026-03-31)
ROE: 7.739927574325116%
Net margin: 5.0102824334680385%
Asset turnover: 0.3174579034377159
Equity multiplier (leverage): 4.8661842081466995
EBIT margin: 6.634820105426184%
Interest burden factor: 0.8784134750732556
Tax burden factor: 0.8596745435258537
ROE archetype: Standard Business
DuPont ROE decomposition for ACR (quarterly period ending 2025-03-31)
ROE: -0.12396440904622327%
Net margin: -3.2113868956593343%
Asset turnover: 0.009551975172280507
Equity multiplier (leverage): 4.04120794916097
ROE archetype: Low Return
DuPont ROE decomposition for ACR (quarterly period ending 2025-06-30)
ROE: 1.0389895084894578%
Net margin: 20.801901888172633%
Asset turnover: 0.012157563084762776
Equity multiplier (leverage): 4.108294675692555
Tax burden factor: 1.0505656892172708
ROE archetype: Low Return
DuPont ROE decomposition for ACR (quarterly period ending 2025-09-30)
ROE: 4.14919824394214%
Net margin: 52.80297267247938%
Asset turnover: 0.019491553213542803
Equity multiplier (leverage): 4.031432240146315
Tax burden factor: 1
ROE archetype: Low Return
DuPont ROE decomposition for ACR (quarterly period ending 2025-12-31)
ROE: 1.2861729806221343%
Net margin: 34.119674691657245%
Asset turnover: 0.009642662667024321
Equity multiplier (leverage): 3.9092867373943374
Tax burden factor: 1.02690873723456
ROE archetype: Low Return
DuPont ROE decomposition for ACR (quarterly period ending 2026-03-31)
ROE: 1.361899205347734%
Net margin: 35.5765595463138%
Asset turnover: 0.00910407276030022
Equity multiplier (leverage): 4.204799573049665
Tax burden factor: 0.9998671802364192
ROE archetype: Low Return
DuPont ROE decomposition for ACS.V (annual period ending 2022-05-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for ACS.V (annual period ending 2023-05-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for ACS.V (annual period ending 2024-05-31)
Asset turnover: 0
ROE archetype: Standard Business
DuPont ROE decomposition for ACT.DE (quarterly period ending 2024-12-31)
ROE: 7.308491307218841%
Net margin: 10.905573256424455%
Asset turnover: 0.2873739732879176
Equity multiplier (leverage): 2.332017486781285
EBIT margin: 14.890066815785497%
Interest burden factor: 1.007003815872096
Tax burden factor: 0.7273119723714505
ROE archetype: Standard Business
DuPont ROE decomposition for ACT.DE (quarterly period ending 2025-03-31)
ROE: 6.941009892990195%
Net margin: 10.116118330107824%
Asset turnover: 0.2836121507132245
Equity multiplier (leverage): 2.4192677126277577
EBIT margin: 14.383466961570363%
Interest burden factor: 0.9727534839019701
Tax burden factor: 0.723015363335474
ROE archetype: Standard Business
DuPont ROE decomposition for ACT.DE (quarterly period ending 2025-06-30)
ROE: 7.466468377664177%
Net margin: 11.1114999405091%
Asset turnover: 0.26776424287856077
Equity multiplier (leverage): 2.5095159525835258
EBIT margin: 16.9975993672968%
Interest burden factor: 0.9059952235856049
Tax burden factor: 0.7215379720947144
ROE archetype: Standard Business
DuPont ROE decomposition for ACT.DE (quarterly period ending 2025-12-31)
ROE: 7.027911038146552%
Net margin: 12.223031539077866%
Asset turnover: 0.23455766088145774
Equity multiplier (leverage): 2.451306975351427
EBIT margin: 19.245392963799258%
Interest burden factor: 0.8726818560290667
Tax burden factor: 0.727773440888195
ROE archetype: Standard Business
DuPont ROE decomposition for ACT.DE (quarterly period ending 2026-03-31)
ROE: 6.662484049299035%
Net margin: 12.109409160931834%
Asset turnover: 0.23106289630857538
Equity multiplier (leverage): 2.3811295013274916
EBIT margin: 17.211223453277093%
Interest burden factor: 0.9629470392808286
Tax burden factor: 0.7306490238259529
ROE archetype: Standard Business
DuPont ROE decomposition for ACV (quarterly period ending 2025-01-31)
Equity multiplier (leverage): 1.4507487871757014
ROE archetype: Standard Business
DuPont ROE decomposition for ACV (quarterly period ending 2026-01-31)
Equity multiplier (leverage): 1.4255658047675142
ROE archetype: Standard Business
DuPont ROE decomposition for AD.AS (annual period ending 2022-12-31)
ROE: 16.527101590392725%
Net margin: 2.9269750758760233%
Asset turnover: 1.7914529914529913
Equity multiplier (leverage): 3.1518987341772142
EBIT margin: 3.5696219994481746%
Interest burden factor: 1.0357487922705313
Tax burden factor: 0.7916666666666667
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for AD.AS (annual period ending 2023-12-31)
ROE: 12.703160718535237%
Net margin: 2.111930038091374%
Asset turnover: 1.8817550662573923
Equity multiplier (leverage): 3.19645924526397
EBIT margin: 2.740775801834697%
Interest burden factor: 0.9457236842105262
Tax burden factor: 0.8147826086956522
ROE archetype: Standard Business
DuPont ROE decomposition for AD.AS (annual period ending 2024-12-31)
ROE: 11.310350723460644%
Net margin: 1.974103875465828%
Asset turnover: 1.737599869325614
Equity multiplier (leverage): 3.2972835495522452
EBIT margin: 2.632138500621104%
Interest burden factor: 0.9447278911564626
Tax burden factor: 0.7938793879387939
ROE archetype: Standard Business
DuPont ROE decomposition for AD.AS (annual period ending 2025-12-31)
ROE: 16.242064633768138%
Net margin: 2.4514899514899513%
Asset turnover: 1.9444415323681663
Equity multiplier (leverage): 3.4073459352616107
EBIT margin: 3.3372314622314625%
Interest burden factor: 0.9393251135626217
Tax burden factor: 0.7820379965457687
ROE archetype: Leverage-Driven Returns
DuPont ROE decomposition for ADBE (quarterly period ending 2025-02-28)
ROE: 13.829705994654448%
Net margin: 31.69408470423521%
Asset turnover: 0.19075279586045735
Equity multiplier (leverage): 2.2875143184421534
EBIT margin: 37.85439271963598%
Interest burden factor: 1.008784096162737
Tax burden factor: 0.8299725022914757
ROE archetype: Standard Business
DuPont ROE decomposition for ADBE (quarterly period ending 2025-05-31)
ROE: 13.779896508169335%
Net margin: 28.792780521028433%
Asset turnover: 0.20230098859839482
Equity multiplier (leverage): 2.3657254614350323
EBIT margin: 35.91009705431637%
Interest burden factor: 0.9962067330488383
Tax burden factor: 0.8048548310328415
ROE archetype: Standard Business
DuPont ROE decomposition for ADBE (quarterly period ending 2025-08-31)
ROE: 15.264019295374279%
Net margin: 29.592518370073478%
Asset turnover: 0.21061887761383022
Equity multiplier (leverage): 2.449005082263761
EBIT margin: 36.28924515698063%
Interest burden factor: 1.0064427059364933
Tax burden factor: 0.8102423411065386
ROE archetype: Balanced Compounder
DuPont ROE decomposition for ADBE (quarterly period ending 2025-11-30)
ROE: 15.867994699269012%
Net margin: 29.964481756538586%
Asset turnover: 0.2126695278969957
Equity multiplier (leverage): 2.490061129397683
EBIT margin: 36.50306748466258%
Interest burden factor: 1.001326846528085
Tax burden factor: 0.8197879858657244
ROE archetype: Balanced Compounder